Krystal Biotech, Inc.

This study is testing whether an investigational eye drop called KB803 can safely reduce the frequency and pain of corneal abrasions (scratches on the eye's surface) in people with dystrophic epidermolysis bullosa (DEB), a rare genetic skin condition. Participants, including chil…

This study is testing an inhaled therapy called KB707 for adults with advanced solid tumors in the lungs that have stopped responding to standard treatments. The therapy uses a modified, harmless virus designed to stimulate the immune system to fight the cancer directly in the lu…

This study is testing a new eye drop called KB801 for people with a specific eye condition called neurotrophic keratitis, which causes slow-healing wounds on the cornea. The goal is to see if the drops are safe and if they can help heal these corneal wounds better than a placebo.…